ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $63,000 | +12.5% | 36,500 | -19.8% | 0.00% | 0.0% |
| Q2 2022 | $56,000 | +19.1% | 45,500 | -35.9% | 0.00% | 0.0% |
| Q1 2022 | $47,000 | -39.0% | 71,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $77,000 | -67.0% | 71,000 | -44.7% | 0.00% | -75.0% |
| Q3 2021 | $233,000 | -45.9% | 128,300 | -21.4% | 0.00% | -50.0% |
| Q2 2021 | $431,000 | +43.2% | 163,300 | +94.9% | 0.01% | +33.3% |
| Q1 2021 | $301,000 | +312.3% | 83,800 | +189.0% | 0.01% | +200.0% |
| Q4 2020 | $73,000 | 0.0% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $73,000 | -24.0% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $96,000 | +35.2% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $71,000 | -48.2% | 29,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $137,000 | +9.6% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $125,000 | -23.3% | 29,000 | +3.6% | 0.00% | -25.0% |
| Q2 2019 | $163,000 | +17.3% | 28,000 | -22.2% | 0.00% | 0.0% |
| Q1 2019 | $139,000 | +113.8% | 36,000 | +2.9% | 0.00% | +100.0% |
| Q4 2018 | $65,000 | +85.7% | 35,000 | +218.2% | 0.00% | +100.0% |
| Q3 2018 | $35,000 | +6.1% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $33,000 | -35.3% | 11,000 | -15.4% | 0.00% | 0.0% |
| Q1 2018 | $51,000 | -7.3% | 13,000 | -3.0% | 0.00% | 0.0% |
| Q4 2017 | $55,000 | -36.0% | 13,400 | -4.3% | 0.00% | -50.0% |
| Q3 2017 | $86,000 | -23.2% | 14,000 | -22.2% | 0.00% | -33.3% |
| Q2 2017 | $112,000 | +49.3% | 18,000 | +50.0% | 0.00% | +50.0% |
| Q1 2017 | $75,000 | -53.1% | 12,000 | -60.0% | 0.00% | -60.0% |
| Q4 2016 | $160,000 | +44.1% | 30,000 | +53.8% | 0.01% | +66.7% |
| Q3 2016 | $111,000 | +0.9% | 19,500 | -3.0% | 0.00% | 0.0% |
| Q2 2016 | $110,000 | -22.5% | 20,100 | +4.8% | 0.00% | -25.0% |
| Q1 2016 | $142,000 | -12.9% | 19,181 | -2.6% | 0.00% | -20.0% |
| Q4 2015 | $163,000 | -2.4% | 19,700 | +5.9% | 0.01% | 0.0% |
| Q3 2015 | $167,000 | +35.8% | 18,600 | +81.7% | 0.01% | +66.7% |
| Q2 2015 | $123,000 | +13.9% | 10,238 | +2.4% | 0.00% | 0.0% |
| Q1 2015 | $108,000 | +176.9% | 10,000 | 0.0% | 0.00% | +200.0% |
| Q3 2013 | $39,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
| MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
| MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
| MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
| EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
| Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
| Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
| CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |